Stocks dip as government shutdown continues, rare earths rally: What to watch this week

U.S. equity markets experienced their steepest daily declines in months, contrasting with gold's eight-week rally, as a government shutdown delays critical economic data, complicating the Federal Reserve's upcoming policy decisions and creating uncertainty for the healthcare sector regarding Affordable Care Act subsidies. Concurrently, Q3 earnings season is commencing with major bank reports, while geopolitical tensions are fueling a 'rare earth Renaissance,' driving significant gains in U.S. rare earth mineral companies following China's export controls and heightened U.S. efforts to secure domestic supply chains.

Analysis

U.S. equity markets experienced their worst daily performance since April 10 for the S&P 500, Nasdaq, and Russell 2000, while the Dow saw its steepest decline since May. This broad market weakness contrasts with gold's eighth consecutive week of gains, signaling a flight to safety amid heightened uncertainty. The ongoing government shutdown is delaying critical economic data releases, including CPI and retail sales, which complicates the Federal Reserve's assessment during its upcoming blackout period.

The shutdown's direct market impact has been described as "de minimis" by Deutsche Bank, yet tariff threats continue to influence market direction. The healthcare sector faces significant legislative risk, with the potential expiration of Affordable Care Act subsidies threatening customer bases for providers like UnitedHealth (UNH) and Humana (HUM), and margins for ACA-focused Centene (CNC). Conversely, positive signals on subsidy deals can trigger rallies in healthcare stocks.

The third-quarter earnings season is commencing, with major banks like JPMorgan Chase (JPM) and Goldman Sachs (GS) leading the reports, alongside key companies such as Johnson & Johnson (JNJ) and Taiwan Semiconductor Manufacturing (TSM). Concurrently, escalating geopolitical tensions, driven by China's rare earth export controls, are fueling a "rare earth Renaissance" in the West. This has led to substantial gains for US-based rare earth companies, including MP Materials (+9%) and Trilogy Metals (+185%), supported by strategic US government investments to secure domestic supply chains.

Key Decisions for Investors

• Investors should closely monitor developments regarding the government shutdown and the subsequent release of delayed economic data, as these will significantly influence Federal Reserve policy and broader market sentiment
• Evaluate exposure to the healthcare sector, particularly companies with high reliance on Affordable Care Act subsidies, given the ongoing legislative uncertainty and potential for significant customer base or margin impacts
• Consider strategic long-term positions in domestic rare earth mineral companies, given the escalating geopolitical tensions and concerted efforts by the US government to secure critical supply chains away from China